ResMed | RMD - Ebit



ResMed reported $455.06M in EBIT for its fiscal quarter ending in June of 2025.


Ebit Change Date
Ansell USD 117.3M 39.1M Jun/2024
AtriCure USD -3820000 2.13M Jun/2025
Baxter International USD 272M 120M Jun/2025
Cochlear AUD 275M 25.5M Dec/2024
Cooper Companies USD 177.3M 72.2M Jul/2025
CSL USD 2.75B 1.35B Dec/2024
Dexcom USD 245.8M 102.7M Jun/2025
Edwards Lifesciences USD 430.9M 19.6M Jun/2025
Fisher Paykel Healthcare NZD 514.4M 296.3M Mar/2025
Globus Medical USD -125953000 224.01M Jun/2025
Haemonetics USD 70.84M 11.5M Jun/2025
Hologic USD 263.9M 37.7M Jun/2025
Idexx Laboratories USD 373.05M 56.51M Jun/2025
Insulet USD 121.1M 32.3M Jun/2025
Integra LifeSciences USD -509910000 498.69M Jun/2025
Intuitive Surgical USD 746.9M 20.6M Jun/2025
Masimo USD 64.5M 42.4M Jun/2025
Medtronic USD 1.52B 969M Jul/2025
Philips EUR 488M 134M Jun/2025
Ramsay Health Care AUD 500.1M 14.8M Dec/2024
ResMed USD 455.06M 10.46M Jun/2025
Sigma Healthcare AUD 6.86M 2.15M Jul/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Steris USD 316.5M 51.12M Jun/2025
Teleflex USD 156.95M 29.47M Jun/2025
Thermo Fisher Scientific USD 1.92B 353M Jun/2025